ZYG11B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.609000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.106200E-01
Normal-vs-Stage2
6.560600E-01
Normal-vs-Stage3
7.086000E-02
Normal-vs-Stage4
9.605600E-01
Stage1-vs-Stage2
9.422400E-01
Stage1-vs-Stage3
1.179030E-01
Stage1-vs-Stage4
5.714400E-01
Stage2-vs-Stage3
1.202580E-01
Stage2-vs-Stage4
5.608600E-01
Stage3-vs-Stage4
9.190300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.449400E-01
Normal-vs-AfricanAmerican
9.233000E-01
Normal-vs-Asian
4.073400E-01
Caucasian-vs-AfricanAmerican
4.148400E-01
Caucasian-vs-Asian
3.711800E-01
AfricanAmerican-vs-Asian
2.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.187800E-01
Normal-vs-Female
7.359000E-01
Male-vs-Female
3.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.485600E-01
Normal-vs-Age(41-60Yrs)
8.642800E-01
Normal-vs-Age(61-80Yrs)
5.040000E-01
Normal-vs-Age(81-100Yrs)
2.970000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.111400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.174800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.881600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.957900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.489800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.035000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.050200E-01
Normal-vs-Daily Drinker
3.278000E-01
Normal-vs-Weekly Drinker
4.200600E-01
Normal-vs-Occasional Drinker
6.649400E-01
Normal-vs-Social Drinker
8.669600E-01
Non Drinker-vs-Daily Drinker
8.746600E-01
Non Drinker-vs-Weekly Drinker
6.813600E-01
Non Drinker-vs-Occasional Drinker
2.977800E-01
Non Drinker-vs-Social Drinker
9.220400E-02
Daily Drinker-vs-Weekly Drinker
7.878200E-01
Daily Drinker-vs-Occasional Drinker
3.874600E-01
Daily Drinker-vs-Social Drinker
1.157830E-01
Weekly Drinker-vs-Occasional Drinker
6.002600E-01
Weekly Drinker-vs-Social Drinker
1.889240E-01
Occasional Drinker-vs-Social Drinker
3.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.642200E-01
Normal-vs-Grade 2
1.282580E-01
Normal-vs-Grade 3
1.692020E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.027200E-01
Grade 1-vs-Grade 3
4.085800E-01
Grade 1-vs-Grade 4
3.642200E-01
Grade 2-vs-Grade 3
6.895000E-01
Grade 2-vs-Grade 4
1.282580E-01
Grade 3-vs-Grade 4
1.692020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.314200E-01
Normal-vs-NonDiabetic
5.853000E-01
Diabetic-vs-NonDiabetic
3.981200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.426000E-01
Normal-vs-NoPancreatitis
5.568800E-01
Pancreatitis-vs-NoPancreatitis
9.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.638600E-01
Normal-vs-N1
6.841000E-01
N0-vs-N1
7.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.312200E-01
Normal-vs-TP53-NonMutant
9.038400E-01
TP53-Mutant-vs-TP53-NonMutant
3.440400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
